Ken Griffin Sight Sciences, Inc. Transaction History
Citadel Advisors LLC
- $505 Billion
- Q3 2024
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Sight Sciences, Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 27,300 shares of SGHT stock, worth $95,823. This represents 0.0% of its overall portfolio holdings.
Number of Shares
27,300
Previous 300
9000.0%
Holding current value
$95,823
Previous $2,000
8450.0%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding SGHT
# of Institutions
81Shares Held
21.6MCall Options Held
66.8KPut Options Held
13K-
Kck Ltd. Tortola, D84.65MShares$16.3 Million22.26% of portfolio
-
Ubs Group Ag2.53MShares$8.89 Million0.0% of portfolio
-
Black Rock Inc. New York, NY2.12MShares$7.45 Million0.0% of portfolio
-
Bank Of America Corp Charlotte, NC2.1MShares$7.39 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.69MShares$5.93 Million0.0% of portfolio
About Sight Sciences, Inc.
- Ticker SGHT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 47,826,200
- Market Cap $168M
- Description
- Sight Sciences, Inc., an ophthalmic medical device company, engages in the development and commercialization of surgical and nonsurgical technologies for the treatment of eye diseases. The company's products include OMNI Surgical System, a therapeutic device used by ophthalmic surgeons to reduce intraocular pressure in adult glaucoma patients; a...